InvestorsHub Logo
Followers 0
Posts 114
Boards Moderated 0
Alias Born 08/11/2020

Re: None

Wednesday, 08/19/2020 1:38:31 PM

Wednesday, August 19, 2020 1:38:31 PM

Post# of 113758
SBFM RELEASED 10Q TODAY, OS reduced 73M to 200M, Sharebuyback!

From the 10-Q posted TODAY 8/19/2020

The number of shares of the registrant’s only class of Common Stock issued and outstanding as of August 18, 2020, was 200,308,644 shares.

https://sec.report/Document/0001654954-20-009340/

https://sec.report/Ticker/SBFM

SBFM is also in the process or distributing generic products by Astrazeneca!

The following drugs will or are available by SBFM:

Anastrozole (brand name Arimidex® by AstraZeneca) for treatment of Breast Cancer
Letrozole (brand name Femara® by Novartis) for treatment of Breast Cancer
Bicalutamide (brand name Casodex® by AstraZeneca) for treatment of Prostate Cancer
Finasteride (brand name Propecia® by Merck) for treatment of BPH (Benign Prostatic Hyperplasia)

See previous 10-Q, mentioning the generics:

https://sec.report/Document/0001654954-20-005714/
and SBFM's press release

https://sunshinebiopharma.com/press-releases.html
https://sunshinebiopharma.com/drugs-market.html




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News